Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Acq. announced
Director departure
|
|
Graf Acquisition Corp. IV
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Director compensation was amended/approved, Acquisition/merger/asset purchase announced|
Docs:
|
"Amended and Restated Certificate of Incorporation of NKGen Biotech, Inc",
"Amended and Restated Bylaws of NKGen Biotech, Inc",
"Specimen Common Stock Certificate",
"Specimen Warrant Certificate",
"June 26, 2023",
"Amended and Restated Registration Rights Agreement, by and among NKGen Biotech, Inc., members of Graf Acquisition Partners IV LLC, and certain former stockholders of NKGen Operating Biotech, Inc",
"THIRD AMENDED AND RESTATED SPONSOR SUPPORT AND LOCKUP AGREEMENT",
"SECOND AMENDED AND RESTATED SPONSOR SUPPORT AND LOCKUP AGREEMENT",
"Promissory Note issued by NKGen Biotech, Inc. to Lisa J. Ling",
"June 26, 2023" |
|
|
|